-
公开(公告)号:US20130209458A1
公开(公告)日:2013-08-15
申请号:US13816390
申请日:2011-08-10
申请人: Steffen Goletz , Antje Danielczyk , Lars Stoeckl
发明人: Steffen Goletz , Antje Danielczyk , Lars Stoeckl
CPC分类号: C07K16/2863 , A61K2039/505 , C07K16/00 , C07K16/18 , C07K16/3092 , C07K2317/41 , C07K2317/55 , C07K2317/73 , C07K2317/732 , C07K2317/92 , C07K2317/94
摘要: The present invention pertains to a method for controlling the circulation half-life of antibodies by adjusting the amount of sialic acid in the carbohydrates attached to the Fab part of the antibodies. Furthermore, the present invention provides antibodies having an increased circulation half-life.
摘要翻译: 本发明涉及通过调节与抗体Fab部分连接的碳水化合物中的唾液酸的量来控制抗体的循环半衰期的方法。 此外,本发明提供具有增加的循环半衰期的抗体。
-
公开(公告)号:US20120149877A1
公开(公告)日:2012-06-14
申请号:US13302698
申请日:2011-11-22
申请人: Steffen Goletz , Antje Danielczyk , Uwe Karsten , Peter Ravn , Renate Stahn , Peter Astrup Christensen
发明人: Steffen Goletz , Antje Danielczyk , Uwe Karsten , Peter Ravn , Renate Stahn , Peter Astrup Christensen
CPC分类号: A61K51/1045 , A61K47/6851 , A61K47/6903 , A61K2039/505 , C07K16/3076 , C07K2317/24 , C07K2317/622 , C07K2317/626 , C07K2319/00
摘要: The invention relates to recognition molecules which are directed towards tumors and can be used in the diagnosis and therapy of tumor diseases.
摘要翻译: 本发明涉及指向肿瘤并可用于诊断和治疗肿瘤疾病的识别分子。
-
公开(公告)号:US08088357B2
公开(公告)日:2012-01-03
申请号:US10536834
申请日:2003-12-01
申请人: Steffen Goletz , Antje Danielczyk , Uwe Karsten , Peter Ravn , Renate Stahn , Peter Astrup Christensen
发明人: Steffen Goletz , Antje Danielczyk , Uwe Karsten , Peter Ravn , Renate Stahn , Peter Astrup Christensen
IPC分类号: A61K39/395 , C07K16/18 , C07K16/30 , G01N33/574 , G01N33/577
CPC分类号: A61K51/1045 , A61K47/6851 , A61K47/6903 , A61K2039/505 , C07K16/3076 , C07K2317/24 , C07K2317/622 , C07K2317/626 , C07K2319/00
摘要: The invention relates to recognition molecules which are directed towards tumors and can be used in the diagnosis and therapy of tumor diseases.
摘要翻译: 本发明涉及指向肿瘤并可用于诊断和治疗肿瘤疾病的识别分子。
-
14.USE OF HUMAN CELLS OF MYELOID LEUKAEMIA ORIGIN FOR EXPRESSION OF ANTIBODIES 有权
标题翻译: 用于表达抗体的MYELOID LEUKEMIA原始人类细胞的使用公开(公告)号:US20100028947A1
公开(公告)日:2010-02-04
申请号:US12440562
申请日:2007-09-10
申请人: Steffen Goletz , Antje Danielczyk , Hans Baumeister , Renate Stahn , Anja Löffler , Lars Stöckl
发明人: Steffen Goletz , Antje Danielczyk , Hans Baumeister , Renate Stahn , Anja Löffler , Lars Stöckl
CPC分类号: C07K16/461 , C07K14/59 , C07K16/00 , C07K16/2863 , C07K16/3092 , C07K2317/24 , C07K2317/41 , C07K2317/72 , C07K2317/732 , C07K2317/734
摘要: The invention relates to a method for producing a protein molecule composition having a defined glycosylation pattern, comprising (a) introducing in a host cell which is an immortalized human blood cell at least one nucleic acid encoding at least a part of said protein; and (b) culturing said host cell under conditions which permit the production of said protein molecule composition; and (c) isolating said protein molecule composition.
摘要翻译: 本发明涉及生产具有确定的糖基化图案的蛋白质分子组合物的方法,其包括(a)在宿主细胞中引入至少一种编码所述蛋白质的至少一部分的至少一种核酸,所述宿主细胞是永生化的人血细胞; 和(b)在允许产生所述蛋白质分子组合物的条件下培养所述宿主细胞; 和(c)分离所述蛋白质分子组合物。
-
-
-